- Welcome to the Institute's new Internet
- Stem cell technique offers new potential to treat blindness
- 20% of adult obesity might be caused by infant nutrition
- Study to reduce birth defects
- Beta thalassaemia gene therapy success
- Genetic link with human male infertility identified
- New research into Congenital Toxoplasmosis endorses UK health guidance for pregnant women
- ICH Poster Competition and Open Day
- Is 'breast only' for first six months best?
- Six months of exclusive breast feeding: how good is the evidence?
- Major new programme to tackle childhood obesity launched
- Study shows that early detection of Severe Combined Immunodeficiency would save lives
- £28 Million boost to understand child health
- The impact of sex selection and abortion in China, India and South Korea
- Regenerative medicine success for muscles
- New study examines early-onset eating disorders in under-13s
- International 50-year mortality trends in children and young people reveal an inadequate response to the health problems and causes of death in adolescents, particularly young men
- Apples, oranges and jam – the tasty way to keep kidney disease at bay
- Scientists prove heart has built-in repair mechanism: Exciting breakthrough towards mending broken hearts
- Fight for Sight awards £1 million for retinal disease research
- New Policy Research Unit in the Health of Children, Young People and Families
- UCLB and NCYPE announce a commercialisation agreement with Special Products Limited for Epistatus®
- Molecular scalpel hope for Duchenne muscular dystrophy
- Eating disorders linked to fertility problems and negative feelings towards pregnancy
- Science: From Cradle to Grave
- £36 million boost for children's health research
- Gene therapy success for children born without functioning immune system
- ICH Open Day 2011
- Under 16s make up less than one per cent of NHS patient surveys
- Mitochondria genes and cardiomyopathy
- Child Health Research PhD Studentships 2012-13
- Tate Liverpool exhibition inspires pioneering science games
- No consistent decrease in child maltreatment despite years of policy initiatives designed to achieve it
- New approach on bone marrow transplant infections
- Genetic testing for antibiotic related deafness
- Great Ormond Street Hospital Children’s Charity announces plans to build a Centre for Children’s Rare Disease Research
- Gene therapy shows clinical effect in third immune disease
- Clean delivery kits linked to substantial reduction in neonatal deaths in South Asia, study shows
- Genetic variant inherited from the mother significantly increases birth weight
- Not enough is known about prescription drug use in pregnancy, say experts
- Improving access to education and employment and reducing the risk of transport-related injury are among the best ways to improve adolescent health
- Research reveals association between red hair gene and rare birthmarks
- Five new UCL fellows of Academy of Medical Sciences
- Surgery boost for children with drug-resistant epilepsy.
- Professor of economics and deputy director appointed to the new UK Birth Cohort Study
- First example of a heritable abnormality affecting semantic cognition found
- New Director of the UCL Institute of Child Health
- New approach to recording suspected child abuse in patient records
- Amniotic fluid yields alternatives to embryonic stem cells
- ICH OPEN DAY AND POSTER COMPETITION
- Europe’s first research centre to battle birth defects
- New cause of thyroid hormone deficiency discovered
- £10 million boost for Centre for Children’s Rare Disease Research
- EU awards grant to develop new drug for Duchenne muscular dystrophy
- New research centre for teenagers with arthritis
- Major study shows steep decline in figure for diagnosed epilepsy
- Obesity leads to vitamin D deficiency
£10 million boost for Centre for Children’s Rare Disease Research
26 November 2012
A centre bringing together the country’s leading clinicians and researchers to find effective treatments for children’s rare diseases has received a £10 million funding boost.
The Centre for Children’s Rare Disease Research will bring together expertise from Great Ormond Street Hospital and University College London, in particular the UCL Institute of Child Health, to advance understanding and find treatments for children’s rare diseases.
The £10 million award from the Higher Education Funding Council for England (HEFCE) is a significant step towards raising the £85 million needed to build and equip the Centre. Great Ormond Street Hospital Children’s Charity has undertaken to raise the remaining amount and the HEFCE funding was given as part of a governmental initiative to support projects which have private funding from industry or the charitable sector worth a minimum of double the public contribution.
Professor David Goldblatt is Director of Clinical Research and Innovation for Great Ormond Street Hospital and the UCL Institute of Child Health and an academic lead for the new Centre. He said: “This is fantastic news. The Centre will provide huge opportunities to advance research into children’s rare diseases and translate discoveries into effective treatment quicker than ever before."
“The work will not simply assist in finding treatments for rare diseases but will inform our understanding of generic and more common disease mechanisms.”
The new Centre, to be built adjacent to Great Ormond Street Hospital and the UCL Institute of Child Health, will work to find treatments and cures for rare diseases, of which there are 6,000 identified. Seventy five per cent of rare diseases affect children. These include rare cancers such as childhood cancers, and some other better known conditions such as cystic fibrosis and muscular dystrophy.
Central to the work of the researchers and clinicians working in the new facility will be finding ways to speed up the delivery of effective treatments, as 30 per cent of children with rare diseases will not live past their fifth birthday.
Great Ormond Street Hospital is uniquely placed to advance research to tackle these life-threatening and life limiting conditions, as it sees many more children with rare disease than any other hospital in the country and is already working with researchers from ICH, many of whom are also clinicians, on ground breaking research in this area.
Current rare disease research
includes work looking at the molecular basis of rare cancers,
ciliopathies and rare obesity syndromes as well as novel genetic
therapies for diverse conditions including inherited muscular
dystrophies and rare immune deficiencies.
For further information, please contact Jenny Gimpel at the GOSH-ICH Press Office on 020 7239 3178, firstname.lastname@example.org.
For genuine and urgent out-of-hours queries call switchboard on 020 7405 9200.
Page last modified on 26 nov 12 11:44